1.Nosocomial Outbreak of COVID-19 in a Hematologic Ward
Jiwon JUNG ; Jungmin LEE ; Seongmin JO ; Seongman BAE ; Ji Yeun KIM ; Hye Hee CHA ; Young-Ju LIM ; Sun Hee KWAK ; Min Jee HONG ; Eun Ok KIM ; Joon-Yong BAE ; Changmin KANG ; Minki SUNG ; Man-Seong PARK ; Sung-Han KIM
Infection and Chemotherapy 2021;53(2):332-341
		                        		
		                        			Background:
		                        			Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. 
		                        		
		                        			Materials and Methods:
		                        			There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transmission. We performed airflow investigation with simulation software, whole-genome sequencing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 
		                        		
		                        			Results:
		                        			Of the nine individuals with COVID-19 who had been in the hematologic ward, six stayed in one multi-patient room (Room 36), and other three stayed in different rooms (Room 1, 34, 35). Guardian in room 35 was close contact to cases in room 36, and patient in room 34 used the shared bathroom for teeth brushing 40 minutes after index used.Airflow simulation revealed that air was spread from the bathroom to the adjacent room 1 while patient in room 1 did not used the shared bathroom. Airflow was associated with poor ventilation in shared bathroom due to dysfunctioning air-exhaust, grill on the door of shared bathroom and the unintended negative pressure of adjacent room. 
		                        		
		                        			Conclusion
		                        			Transmission of SARS-CoV-2 in the hematologic ward occurred rapidly in the multi-patient room and shared bathroom settings. In addition, there was a case of possible airborne transmission due to unexpected airflow.
		                        		
		                        		
		                        		
		                        	
2.Nosocomial Outbreak of COVID-19 in a Hematologic Ward
Jiwon JUNG ; Jungmin LEE ; Seongmin JO ; Seongman BAE ; Ji Yeun KIM ; Hye Hee CHA ; Young-Ju LIM ; Sun Hee KWAK ; Min Jee HONG ; Eun Ok KIM ; Joon-Yong BAE ; Changmin KANG ; Minki SUNG ; Man-Seong PARK ; Sung-Han KIM
Infection and Chemotherapy 2021;53(2):332-341
		                        		
		                        			Background:
		                        			Coronavirus disease 2019 (COVID-19) outbreaks occur in hospitals in many parts of the world. In hospital settings, the possibility of airborne transmission needs to be investigated thoroughly. 
		                        		
		                        			Materials and Methods:
		                        			There was a nosocomial outbreak of COVID-19 in a hematologic ward in a tertiary hospital, Seoul, Korea. We found 11 patients and guardians with COVID-19 through vigorous contact tracing and closed-circuit television monitoring. We found one patient who probably had acquired COVID-19 through airborne-transmission. We performed airflow investigation with simulation software, whole-genome sequencing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 
		                        		
		                        			Results:
		                        			Of the nine individuals with COVID-19 who had been in the hematologic ward, six stayed in one multi-patient room (Room 36), and other three stayed in different rooms (Room 1, 34, 35). Guardian in room 35 was close contact to cases in room 36, and patient in room 34 used the shared bathroom for teeth brushing 40 minutes after index used.Airflow simulation revealed that air was spread from the bathroom to the adjacent room 1 while patient in room 1 did not used the shared bathroom. Airflow was associated with poor ventilation in shared bathroom due to dysfunctioning air-exhaust, grill on the door of shared bathroom and the unintended negative pressure of adjacent room. 
		                        		
		                        			Conclusion
		                        			Transmission of SARS-CoV-2 in the hematologic ward occurred rapidly in the multi-patient room and shared bathroom settings. In addition, there was a case of possible airborne transmission due to unexpected airflow.
		                        		
		                        		
		                        		
		                        	
3.Erratum: Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study.
Se Jin PARK ; Ki Soo PAI ; Jun Mo KIM ; Kwanjin PARK ; Kun Suk KIM ; Sang Hoon SONG ; Sungchan PARK ; Sun Ouck KIM ; Dong Soo RYU ; Minki BAEK ; Sang Don LEE ; Jung Won LEE ; Young Jae IM ; Sang Won HAN ; Jae Min CHUNG ; Min Hyun CHO ; Tae Sun HA ; Won Yeol CHO ; Hong Jin SUH
Journal of Korean Medical Science 2015;30(1):119-119
		                        		
		                        			
		                        			We made a mistake in our recently published article.
		                        		
		                        		
		                        		
		                        	
4.Epidemiologic features of the first MERS outbreak in Korea: focus on Pyeongtaek St. Mary's Hospital.
Kyung Min KIM ; Moran KI ; Sung Il CHO ; Minki SUNG ; Jin Kwan HONG ; Hae Kwan CHEONG ; Jong Hun KIM ; Sang Eun LEE ; Changhwan LEE ; Keon Joo LEE ; Yong Shik PARK ; Seung Woo KIM ; Bo Youl CHOI
Epidemiology and Health 2015;37(1):e2015041-
		                        		
		                        			
		                        			OBJECTIVES: This study investigated the epidemiologic features of the confirmed cases of Middle East Respiratory Syndrome (MERS) in Pyeongtaek St. Mary's Hospital, where the outbreak first began, in order to identify lessons relevant for the prevention and control of future outbreaks. METHODS: The patients' clinical symptoms and test results were collected from their medical records. The caregivers of patients were identified by phone calls. RESULTS: After patient zero (case #1) was admitted to Pyeongtaek St. Mary's Hospital (May 15-May 17), an outbreak occurred, with 36 cases between May 18 and June 4, 2015. Six patients died (fatality rate, 16.7%). Twenty-six cases occurred in the first-generation, and 10 in the second-generation. The median incubation period was five days, while the median period from symptom onset to death was 12.5 days. While the total attack rate was 3.9%, the attack rate among inpatients was 7.6%, and the inpatients on the eighth floor, where patient zero was hospitalized, had an 18.6% attack rate. In contrast, caregivers and medical staff showed attack rates of 3.3% and 1.1%, respectively. CONCLUSIONS: The attack rates were higher than those of the previous outbreaks in other countries. The outbreak spread beyond Pyeongtaek St. Mary's Hospital when four of the patients were moved to other hospitals without appropriate quarantine. The best method of preventing future outbreaks is to overcome the vulnerabilities observed in this outbreak, such as ward crowding, patient migration without appropriate data sharing, and the lack of an initial broad quarantine.
		                        		
		                        		
		                        		
		                        			Caregivers
		                        			;
		                        		
		                        			Cross Infection
		                        			;
		                        		
		                        			Crowding
		                        			;
		                        		
		                        			Disease Outbreaks
		                        			;
		                        		
		                        			Epidemiology
		                        			;
		                        		
		                        			Gyeonggi-do*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Information Dissemination
		                        			;
		                        		
		                        			Inpatients
		                        			;
		                        		
		                        			Korea*
		                        			;
		                        		
		                        			Medical Records
		                        			;
		                        		
		                        			Medical Staff
		                        			;
		                        		
		                        			Middle East
		                        			;
		                        		
		                        			Quarantine
		                        			
		                        		
		                        	
5.Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study.
Se Jin PARK ; Ki Soo PAI ; Jun Mo KIM ; Kwanjin PARK ; Kun Suk KIM ; Sang Hoon SONG ; Sungchan PARK ; Sun Ouck KIM ; Dong Soo RYU ; Minki BAEK ; Sang Don LEE ; Jung Won LEE ; Young Jae IM ; Sang Won HAN ; Jae Min CHUNG ; Min Hyun CHO ; Tae Sun HA ; Won Yeol CHO ; Hong Jin SUH
Journal of Korean Medical Science 2014;29(11):1550-1554
		                        		
		                        			
		                        			We investigated the efficacy and tolerability of various anticholinergics in Korean children with non-neurogenic overactive bladder (OAB). A total of 326 children (males:females= 157:169) aged under 18 yr (mean age 7.3+/-2.6 yr) who were diagnosed with OAB from 2008 to 2011 were retrospectively reviewed. The mean duration of OAB symptoms before anticholinergic treatment was 16.9+/-19.0 months. The mean duration of medication was 5.6+/-7.3 months. Urgency urinary incontinence episodes per week decreased from 1.9+/-3.1 to 0.4+/-1.5 times (P<0.001). The median voiding frequency during daytime was decreased from 9.2+/-5.4 to 6.3+/-4.2 times (P<0.001). According to 3-day voiding diaries, the maximum and average bladder capacity were increased from 145.5+/-66.9 to 196.8+/-80.3 mL and from 80.8+/-39.6 to 121.8+/-56.5 mL, respectively (P<0.001). On uroflowmetry, maximum flow rate was increased from 17.6+/-8.4 to 20.5+/-8.2 mL/sec (P<0.001). Adverse effects were reported in 14 (4.3%) children and six children (1.8%) discontinued medication due to adverse effects. Our results indicate that anticholinergics are effective to improve OAB symptoms and tolerability was acceptable without severe complications in children.
		                        		
		                        		
		                        		
		                        			Child
		                        			;
		                        		
		                        			Child, Preschool
		                        			;
		                        		
		                        			Cholinergic Antagonists/adverse effects/*therapeutic use
		                        			;
		                        		
		                        			Constipation/etiology
		                        			;
		                        		
		                        			Dizziness/etiology
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Treatment Outcome
		                        			;
		                        		
		                        			Urinary Bladder, Overactive/*drug therapy
		                        			
		                        		
		                        	
6.Prolonged shedding of the canine influenza H3N2 virus in nasal swabs of experimentally immunocompromised dogs.
Minki HONG ; Bokyu KANG ; Woonsung NA ; Dongjun AN ; Hyoungjoon MOON ; Doo Jin KIM ; Jinsik OH ; Seong Jun PARK ; Haryoung POO ; Jeong Ki KIM ; Jongman KIM ; Daesub SONG
Clinical and Experimental Vaccine Research 2013;2(1):66-68
		                        		
		                        			
		                        			PURPOSE: The avian origin canine influenza virus H3N2 has been recently isolated and found to be currently in dog population in South Korea and China. The purpose of this study was to clarify the relationship between immunosuppressive glucocorticoids used in veterinary clinical practice and viral shedding pattern of influenza in dogs. MATERIALS AND METHODS: Eight conventional beagle dogs were divided into control infection group and immunocompromised group. Dogs of both groups were infected with H3N2 canine influenza virus (2x106.0 EID50/0.1 mL). Dogs in immunocompromised group were given orally 3.0 mg/kg prednisolone for 7 days. Virus shedding was monitored using real-time polymerase chain reaction. After necropsy, histopathologic lesions were compared. RESULTS: We found that immunocompromised dogs exhibited more prolonged (8 days vs. 13 days) and higher magnitude viral shedding than control group (peak titer of viral shedding 4.6 vs. 5.5 EID50). CONCLUSION: Restricted use of immunosuppressive drugs in the clinical setting might help control the rapid spread of H3N2 through local dog populations.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			China
		                        			;
		                        		
		                        			Dogs
		                        			;
		                        		
		                        			Glucocorticoids
		                        			;
		                        		
		                        			Immunosuppression
		                        			;
		                        		
		                        			Influenza A Virus, H3N2 Subtype
		                        			;
		                        		
		                        			Influenza, Human
		                        			;
		                        		
		                        			Orthomyxoviridae
		                        			;
		                        		
		                        			Prednisolone
		                        			;
		                        		
		                        			Real-Time Polymerase Chain Reaction
		                        			;
		                        		
		                        			Republic of Korea
		                        			;
		                        		
		                        			Viral Load
		                        			;
		                        		
		                        			Virus Shedding
		                        			
		                        		
		                        	
7.A Nationwide Epidemiological Study of Nocturnal Enuresis in Korean Adolescents and Adults: Population Based Cross Sectional Study.
Minki BAEK ; Kwanjin PARK ; Hahn Ey LEE ; Ju Hyung KANG ; Hong Jin SUH ; Ji Hong KIM ; Sang Don LEE ; Ki Soo PAI ; Sang Won HAN ; Yong Hoon PARK ; Kyung Do KIM
Journal of Korean Medical Science 2013;28(7):1065-1070
		                        		
		                        			
		                        			We performed a nationwide epidemiological study to evaluate the prevalence and characteristics of nocturnal enuresis (NE) in Korean adolescents and adults. A questionnaire was sent via e-mail to 51,073 people aged 16-40 yr by stratified sampling according to age, sex, and region among a 200,000 internet survey panel pool. The questionnaire included following information; presence or absence of NE, frequency of NE, possible risk factors for NE, self-esteem scale score and depression score results, and measures for the treatment of NE. Among the 2,117 responders, 54 (2.6%) had NE (> or =1 enuretic episode within 6 months). Of 54 bedwetters, 9.3% wet > or =1 night per week and 20.5% wet > or =1 per month. The prevalence rates remained relatively stable with no apparent trend of reduction with age. The presence of sleep disturbance, family history, urgency, or urge incontinence increased the probability of NE episode significantly. The self-esteem score was lower (P=0.053) and the depression scale score was higher (P=0.003) in bedwetters compared with non-bedwetters. Overall 2.6% of Korean aged 16-40 yr have NE. The higher rate of urgency and urge incontinence in adolescent and adult enuretics suggests that bladder function has an important role in adolescent and adult NE.
		                        		
		                        		
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Cross-Sectional Studies
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Nocturnal Enuresis/*epidemiology
		                        			;
		                        		
		                        			Prevalence
		                        			;
		                        		
		                        			Questionnaires
		                        			;
		                        		
		                        			Republic of Korea/epidemiology
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Sleep Disorders
		                        			;
		                        		
		                        			Urinary Incontinence/epidemiology
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
8.HDL Cholesterol Reduction during Rosiglitazone and Fenofibrate Treatment in a Type 2 Diabetes Mellitus Patient with Dyslipidemia.
Mijeong IM ; Minki KIM ; Jin Kyung LEE ; Yoon Hwan CHANG ; Dong Young LEE ; Seok Il HONG ; Yun Yong LEE ; Young Jun HONG
The Korean Journal of Laboratory Medicine 2010;30(1):17-19
		                        		
		                        			
		                        			Thiazolidinediones (TZD), which are widely used as insulin sensitizers, and fibrates, which are lipid-lowering drugs, are used in the treatment of dyslipidemia that commonly accompanies diabetes. Several reports suggest elevated levels of high-density lipoprotein (HDL) cholesterol, but the paradoxical reduction of HDL cholesterol level during single or combined TZD and fibrate therapies has been occasionally reported. Herein, we report a case of paradoxical decrease in HDL cholesterol and apolipoprotein A-1 levels during rosiglitazone and fenofibrate treatment for the first time in Korea. The patient was a 56-yr-old man presenting with type 2 diabetes mellitus and dyslipidemia. His HDL cholesterol and apolipoprotein A-1 levels returned to normal after the cessation of fenofibrate therapy. Since diabetes is an established risk factor of cardiovascular diseases, low HDL cholesterol can be a key cause of concern for patients with diabetes. Therefore, HDL cholesterol level should be determined before and after starting TZD and/or fibrate therapy in diabetic patients.
		                        		
		                        		
		                        		
		                        			Apolipoprotein A-I/metabolism
		                        			;
		                        		
		                        			Cholesterol, HDL/*blood
		                        			;
		                        		
		                        			Diabetes Mellitus, Type 2/complications/*drug therapy
		                        			;
		                        		
		                        			Dyslipidemias/complications/*drug therapy
		                        			;
		                        		
		                        			Fenofibrate/*therapeutic use
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypolipidemic Agents/*therapeutic use
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Thiazolidinediones/*therapeutic use
		                        			
		                        		
		                        	
9.A Case of del(16)(q22) in a Patient with Acute Myeloid Leukemia with Complex Karyotype.
Minki KIM ; Ji Won LEE ; Jin Kyung LEE ; Young Jun HONG ; Seok Il HONG ; Hye Jin KANG ; Eun Hae CHO ; Yoon Hwan CHANG
The Korean Journal of Laboratory Medicine 2010;30(4):329-333
		                        		
		                        			
		                        			Inversion of chromosome 16 [inv(16)(p13.1q22)] and t(16;16)(p13.1;q22) are associated with acute myelomonocytic leukemia (AMML) with eosinophilia and a favorable prognosis. On the other hand, patients with del(16)(q22) usually present with MDS or chronic myelomonocytic leukemia (CMML), which can evolve to AMML without eosinophilia, and this chromosomal aberration is associated with older age, a complex karyotype, and a poor prognosis. We report a case of AML with del(16)(q22) which showed a complex karyotype, absence of eosinophilia in bone marrow study and a poor response to chemotherapy.
		                        		
		                        		
		                        		
		                        			Antimetabolites, Antineoplastic/therapeutic use
		                        			;
		                        		
		                        			*Chromosome Deletion
		                        			;
		                        		
		                        			*Chromosomes, Human, Pair 16
		                        			;
		                        		
		                        			Cytarabine/therapeutic use
		                        			;
		                        		
		                        			Daunorubicin/therapeutic use
		                        			;
		                        		
		                        			Drug Therapy, Combination
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			In Situ Hybridization, Fluorescence
		                        			;
		                        		
		                        			Karyotyping
		                        			;
		                        		
		                        			Leukemia, Myeloid, Acute/diagnosis/drug therapy/*genetics
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Monocyte-Macrophage Precursor Cells/cytology
		                        			;
		                        		
		                        			Prognosis
		                        			
		                        		
		                        	
10.Late-onset Neutropenia Following Rituximab Therapy as a Treatment of Diffuse Large B-cell Lymphoma: A Single Institution Study.
Minki KIM ; Jin Kyung LEE ; Young Jun HONG ; Seok Il HONG ; Hye Jin KANG ; Yoon Hwan CHANG
The Korean Journal of Laboratory Medicine 2010;30(6):575-579
		                        		
		                        			
		                        			BACKGROUND: Late-onset neutropenia (LON) following rituximab therapy has been reported in recent years. However, its incidence has not been reported in Korea. The aim of this study is to investigate the incidence of LON after rituximab therapy in Korean patients with diffuse large B-cell lymphoma (DLBCL). METHODS: Ninety-eight cases of DLBCL treated with rituximab between 2004 and 2008 were evaluated. We identified LON as defined by the neutrophil count of <1.5x10(9)/L without apparent cause after the recovery of neutrophil count following rituximab therapy. Bone marrow aspiration and biopsy specimens at the time of neutropenia were available for retrospective review in only 5 of the patients. RESULTS: LON was observed in 15 (15.3%) of the 98 patients. In the bone marrow specimens of the 5 patients, promyelocytes were relatively increased and the maturation index of the granulopoiesis was 2:1-3:1, which reflects maturation arrest. CONCLUSIONS: The incidence of LON following rituximab therapy was 15.3% in Korean patients with DLBCL. Although there are several hypotheses about the causative mechanisms of LON, we suggest that maturation arrest at the promyelocyte stage of granulopoiesis may be one of the mechanisms involved in the development of LON.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Antibodies, Monoclonal, Murine-Derived/adverse effects/*therapeutic use
		                        			;
		                        		
		                        			Antineoplastic Agents/adverse effects/*therapeutic use
		                        			;
		                        		
		                        			Bone Marrow Cells/pathology
		                        			;
		                        		
		                        			Cell Differentiation
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lymphoma, Large B-Cell, Diffuse/*drug therapy
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Neutropenia/diagnosis/*epidemiology
		                        			;
		                        		
		                        			Retrospective Studies
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail